Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

2018 France Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,450.00

... from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 260 pages

2018 Germany Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,450.00

... from VPGMarketResearch.com provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 262 pages

2018 Italy Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,450.00

... from VPGMarketResearch.com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 260 pages

2018 Japan Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,750.00

... from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 260 pages

2018 Spain Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,450.00

... from VPGMarketResearch.com provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 260 pages

2018 UK Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 2,450.00

... report from VPGMarketResearch.com provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 260 pages

2018 US Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

US$ 3,500.00

... report from VPGMarketResearch.com provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

April 2018 262 pages

Global Pneumococcal Vaccine Market - Forecasts from 2018 to 2023

US$ 3,600.00

... towards public health is fuelling the development of pneumococcal vaccines in the developing countries. Major market players in the global pneumococcal vaccine market are Pfizer, Sanofi, GSK, Merck, AstraZeneca ...

April 2018 75 pages

Aneurysmal Subarachnoid Hemorrhage Drugs Market by Drug Class (Opioid Analgesic, Calcium Channel Blocker, Anticonvulsant, Stool Softener, Osmotic Agent/Diuretic, and Other Drugs) - Global Opportunity Analysis and Industry Forecast, 2017-2023

US$ 5,370.00

... high fatality and permanent disability rates. The global aneurysmal subarachnoid hemorrhage drugs market was valued at $160,269 thousand in 2016 ... current and emerging trends, and dynamics in the global aneurysmal subarachnoid hemorrhage drugs market to identify the prevailing opportunities. It presents a ...

April 2018 142 pages

Global Malignant Melanoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

US$ 3,000.00

... Drug Market Overview Dosage, Price & Patent Insight Global Malignant Melanoma Drug Clinical Pipeline: 197 Drugs Marketed Malignant Melanoma Drug Clinical Insight: 25 Drugs Sales Analysis of Global Melanoma Therapeutics Regional Analysis of the Melanoma Drug Market Melanoma occurs due to mutations in the skin ...

April 2018 470 pages

Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024

US$ 2,400.00

... Working Mechanism of Personalized Cancer Vaccine Relevance of Biomarkers In Personalized Vaccines Developmental Cost Analysis of a Personalized Cancer Vaccine Advancements in the Personalized Cancer Vaccine Personalized Cancer Vaccine Market Analysis by Cancer Vaccines are therapeutics that helps protect ...

April 2018 140 pages

Global Cell Therapy Market, Price, Product & Clinical Pipeline Outlook 2024

US$ 2,400.00

... potential. Kuick Research Report on the Global cell therapy market provides a detailed insight into the current scenario of the cell therapy market worldwide. Key data like pricing of cell therapy products, cost analysis of cell therapy ...

April 2018 1200 pages

India Insulin Lispro Market Report 2018

US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Insulin Lispro market size to maintain the average annual growth rate of 7.39% ... the next few years, Insulin Lispro market size will be further expanded, we expect that by 2022, The market size of the Insulin Lispro will reach 66 million $. ...

March 2018 118 pages

Global Vitamin B & C Ingredients Market Report 2018

US$ 2,350.00

... $ in 2017, BisReport analysts believe that in the next few years, Vitamin B & C Ingredients market size will be further expanded, we expect ... Africa, GCC) Section (5 6 7): 500 USD- Product Type Segmentation (Vitamin C, Vitamin B) Industry Segmentation (Pharmaceuticals, Food & Beverages, Cosmetics, Animal Feeds, ...

March 2018 120 pages

Benchmarking Pharma’s MSL Capabilities

US$ 2,495.00

... included in Benchmarking Pharma's MSL Capabilities The need for on-demand MSLs is rising; ... Benchmarking Pharma's MSL Capabilities Mark Rees-Saunders, Medical Affairs Excellence Lead, AstraZeneca UK Senior MSL Manager, Top 10 Pharma Company, UK MSL Director, Specialty Pharma Company, UK Carmen Sanchez Puyol, MSL ...

March 2018 -

Drugs of Abuse Testing - Global Market Outlook (2017-2026)

US$ 4,150.00

... the use of illegal drugs. The drug of abuse testing can be performed for a variety of reasons such as Employment drug testing, medical screening, athletics testing, and legal forensic information ...

March 2018 148 pages

Global Parkinson’s Disease Treatment Market(By Product- Carbidopa/Levodopa, Dopamine Receptor Agonists, Mao Inhibitors, Comt Inhibitors, Anticholinergics, and Other Drugs, By Channel Of Distribution- Hospitals, Healthcare Institutes and Others, By Geography- North America, Europe, Asia-Pacific, Middle-East and Africa and Latin America)

US$ 4,795.00

... global market. The global Parkinson’s disease treatment market has been segmented into: Global Parkinson’s Disease Treatment Market: By Product Carbidopa/levodopa, Dopamine Receptor Agonists, MAO inhibitors COMT inhibitors, Anticholinergics, Other drugs Global Parkinson’s Disease Treatment Market ...

March 2018 148 pages

Asia-Pacific Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... report. The Asia-Pacific injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 388 pages

Europe Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... report. The Europe injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 394 pages

Global Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 4,200.00

... report. The global injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 741 pages

North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... Distribution Channel Application Geography The North America injectable drug delivery market is segmented on of ... North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery ...

March 2018 269 pages

Global Oncology Drugs Market 2018-2024

US$ 2,750.00

... for the manufacturers of cancer drugs. Market Analysis: The global oncology drugs market is estimated to witness a CAGR of 7.0% during the forecast period 2018–2024. The market is analyzed based on three segments ...

March 2018 102 pages

Global Respiratory Drugs Market 2018-2024

US$ 2,750.00

... underlying causes, ranging from inherited mutations to pathological inflammation. The respiratory disorders market is dominated by long-acting beta-agonist (LABA) and ... and asthma. These drugs stimulate muscles surrounding the bronchial tubes to suppress and open the airways. Respiratory therapy area consists ...

March 2018 113 pages

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H1 2018

US$ 3,500.00

... Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 28 pages

Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cathepsin S (CTSS or EC 3.4.22.27) development landscape Develop and design in-licensing and ...

March 2018 31 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H1 2018

US$ 3,500.00

... Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 57 pages

Gamma Secretase (EC 3.4.23.) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Gamma Secretase (EC 3.4.23.) development landscape Develop and design in-licensing and ...

March 2018 53 pages

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) - Pipeline Review, H1 2018

US$ 3,500.00

... Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 50 pages

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) development landscape Develop and design ...

March 2018 48 pages

Human Parainfluenza Virus 3 Infections - Pipeline Review, H1 2018

US$ 2,000.00

... . The Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Parainfluenza Virus 3 Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 32 pages

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) development landscape Develop and design ...

March 2018 52 pages

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) development landscape Develop ...

March 2018 62 pages

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H1 2018

US$ 3,500.00

... Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 73 pages

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) development landscape ...

March 2018 51 pages

Xerostomia - Pipeline Review, H1 2018

US$ 2,000.00

... and Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Xerostomia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 41 pages

Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

US$ 2,750.00

... urinary incontinence and overactive bladder by type. Product type include Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity. Report Includes: 96 data tables. An overview of the global market for drugs for urinary incontinence and overactive bladder Analyses of global market ...

March 2018 179 pages

Vaccine Market in Australia to 2022

US$ 603.13

... future outlook of the vaccine market in Australia to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other business ...

March 2018 13 pages

Vaccine Market in Austria to 2022

US$ 603.13

... size of the vaccine market in Austria? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Austria to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Belgium to 2022

US$ 603.13

... size of the vaccine market in Belgium? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Belgium to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Bulgaria to 2022

US$ 603.13

... size of the vaccine market in Bulgaria? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Bulgaria to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Canada to 2022

US$ 603.13

... size of the vaccine market in Canada? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Canada to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and ...

March 2018 13 pages

Vaccine Market in Chile to 2022

US$ 603.13

... size of the vaccine market in Chile? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Chile to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and ...

March 2018 13 pages

Vaccine Market in China to 2022

US$ 603.13

... size of the vaccine market in China? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in China to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and ...

March 2018 13 pages

Vaccine Market in Colombia to 2022

US$ 603.13

... size of the vaccine market in Colombia? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Colombia to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Czech Republic to 2022

US$ 603.13

... future outlook of the vaccine market in Czech Republic to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other business ...

March 2018 13 pages

Vaccine Market in Denmark to 2022

US$ 603.13

... size of the vaccine market in Denmark? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Denmark to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Ecuador to 2022

US$ 603.13

... size of the vaccine market in Ecuador? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Ecuador to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Estonia to 2022

US$ 603.13

... size of the vaccine market in Estonia? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Estonia to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Vaccine Market in Finland to 2022

US$ 603.13

... size of the vaccine market in Finland? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Finland to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1